AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - AWH ranking 25 / 58

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
688.29
2. Guardant Health GH
433.06
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Inotiv NOTV
17.11
5. Olink Holding OLK
7.63
6. Illumina ILMN
7.28
7. National Research NRC
6.87
8. CareDx CDNA
6.6
9. Global Cord Blood CO
5.67
10. DarioHealth DRIO
5.3
11. Myriad Genetics MYGN
5.08
12. Fulgent Genetics FLGT
4.77
13. Pacific Biosciences of California PACB
4.65
14. Qiagen QGEN
3.86
15. Exact Sciences EXAS
3.82
16. Sotera Health SHC
3.82
17. Syneos Health SYNH
3.71
18. Co-Diagnostics CODX
3.36
19. Sera Prognostics SERA
2.96
20. Psychemedics PMD
2.92
21. Enzo Biochem ENZ
2.89
22. Anixa Biosciences ANIX
2.45
23. Bioventus BVS
2.44
24. NeoGenomics NEO
2.42
25. Aspira Womens Health AWH
2.28
26. Exagen XGN
2.2
27. MDxHealth MDXH
2.15
28. Meridian Bioscience VIVO
2.1
29. Twist Bioscience TWST
2.09
30. Biodesix BDSX
2.04
31. MaxCyte MXCT
1.94
32. Prenetics Global PRE
1.89
33. bioAffinity Technologies BIAF
1.84
34. Laboratory Corp of America Holdings LH
1.81
35. Quest Diagnostics DGX
1.8
36. Personalis PSNL
1.79
37. Organovo Holdings ONVO
1.66
38. Neuronetics STIM
1.65
39. Trinity Biotech TRIB
1.52
40. SeqLL SQL
1.43
41. Waters WAT
1.42
42. Charles River Laboratories CRL
1.17
43. Interpace Biosciences IDXG
1.17
44. PerkinElmer PKI
1.15
45. Precipio PRPO
1.1
46. Agilent Technologies A
0.99
47. IQVIA Holdings IQV
0.84
48. Thermo Fisher Scientific TMO
0.53
49. Heska HSKA
0.52
50. Danaher DHR
0.46
51. Mettler-Toledo MTD
0.45
52. Natera NTRA
0.42
53. RadNet RDNT
0.4
54. IDEXX Laboratories IDXX
0.4
55. DexCom DXCM
0.37
56. Medpace Holdings MEDP
0.34
57. Lantheus Holdings LNTH
0.32
58. Icon ICLR
0.21

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.